Cargando…

Safety and immunogenicity of three doses of an eleven-valent diphtheria toxoid and tetanus protein – conjugated pneumococcal vaccine in Filipino infants

BACKGROUND: An 11-valent pneumococcal conjugate vaccine could provide significantly larger reduction in pneumococcal disease burden than the currently available 7-valent vaccine formulation in many countries. METHODS: In total, 50 infants were enrolled to this open, uncontrolled study, which evaluat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Capeding, Maria Z Rosario, Puumalainen, Taneli, Gepanayao, Connie P, Käyhty, Helena, Lucero, Marilla G, Nohynek, Hanna
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2003
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC184484/ https://www.ncbi.nlm.nih.gov/pubmed/12908876 http://dx.doi.org/10.1186/1471-2334-3-17

Ejemplares similares

Cost of Delivering Tetanus Toxoid and Tetanus-Diphtheria Vaccination in Vietnam and the Budget Impact of Proposed Changes to the Schedule
por: Mai, Vu Quynh, et al.
Publicado: (2022)

Immunogenicity and safety of a tetanus-diphtheria vaccine and a 13-valent pneumococcal conjugate vaccine after concomitant vaccination in ≥ 50-year-old adults
por: Song, Joon Young, et al.
Publicado: (2018)

An open-label randomized clinical trial of prophylactic paracetamol coadministered with 7-valent pneumococcal conjugate vaccine and hexavalent diphtheria toxoid, tetanus toxoid, 3-component acellular pertussis, hepatitis B, inactivated poliovirus, and Haemophilus influenzae type b vaccine
por: Rose, Markus A, et al.
Publicado: (2013)

Guillain-Barré syndrome after tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine: a case report
por: Ammar, Hussam
Publicado: (2011)

Comparative Immunogenicity of the Tetanus Toxoid and Recombinant Tetanus Vaccines in Mice, Rats, and Cynomolgus Monkeys
por: Yu, Rui, et al.
Publicado: (2016)

The data management of a phase III efficacy trial of an 11-valent pneumococcal conjugate vaccine and related satellite studies conducted in the Philippines
por: Sanvictores, Diozele Hazel M, et al.
Publicado: (2012)

A Bordetella pertussis proteoliposome induces protection in mice without affecting the immunogenicity of diphtheria and tetanus toxoids in a trivalent formulation
por: Castillo, Sonsire Fernández, et al.
Publicado: (2016)

Nanoporous Microneedle Arrays Effectively Induce Antibody Responses against Diphtheria and Tetanus Toxoid
por: de Groot, Anne Marit, et al.
Publicado: (2017)

Immunogenicity of MenACWY-CRM in Korean Military Recruits: Influence of Tetanus-Diphtheria Toxoid Vaccination on the Vaccine Response to MenACWY-CRM
por: Kim, Han Wool, et al.
Publicado: (2016)

Post-licensure safety surveillance study of routine use of tetanus toxoid, reduced diphtheria toxoid and 5-component acellular pertussis vaccine
por: Baxter, Roger, et al.
Publicado: (2016)

Immunogenicity and Safety of Diphtheria-tetanus Vaccine in Adults
por: Choi, Jung-Hyun, et al.
Publicado: (2010)

Myocarditis following diphtheria, whole-cell pertussis, and tetanus toxoid vaccination in a young infant
por: Kumar, Vivek, et al.
Publicado: (2018)

Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccines: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2019
por: Havers, Fiona P., et al.
Publicado: (2020)

Effect of Preexisting Immunity to Tetanus Toxoid on the Efficacy of Tetanus Toxoid-Conjugated Heroin Vaccine in Mice
por: Komla, Essie, et al.
Publicado: (2021)

THE PURIFICATION AND CONCENTRATION OF DIPHTHERIA TOXOID
por: Wadsworth, Augustus, et al.
Publicado: (1932)

Cost-Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Versus Lower-Valent Alternatives in Filipino Infants
por: Perdrizet, Johnna, et al.
Publicado: (2021)

Cost-Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Versus Lower-Valent Alternatives in Filipino Infants
por: Dhere, Rajeev, et al.
Publicado: (2022)

1089 Safety and Immunogenicity of DTaP-IPV (Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed Combined with Inactivated Poliovirus Vaccine) Compared to DAPTACEL(®) (Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed) + IPOL(®) (Poliovirus Vaccine Inactivated) as the 5th Dose in Children 4 to 6 Years of Age
por: Smith, Michael, et al.
Publicado: (2014)

Immunization with Tetanus Toxoid: The Recall Response
por: Strenge, Henry B.
Publicado: (1940)

Tetanus toxoid immunization to reduce mortality from neonatal tetanus
por: Blencowe, Hannah, et al.
Publicado: (2010)

Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine (Tdap) in Pregnant Women — Advisory Committee on Immunization Practices (ACIP), 2012
por: Sawyer, Mark, et al.
Publicado: (2013)

Barriers to Receipt of Prenatal Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Among Mothers of Infants Aged <4 Months with Pertussis — California, 2016
por: New, Sarah, et al.
Publicado: (2018)

Comparison of the Safety and Immunogenicity of a Novel Quadrivalent Meningococcal ACWY-Tetanus Toxoid Conjugate Vaccine and a Marketed Quadrivalent Meningococcal ACWY-Diphtheria Toxoid Conjugate Vaccine in Healthy Individuals 10–25 Years of Age
por: Halperin, Scott A., et al.
Publicado: (2014)

Clinical case review: A method to improve identification of true clinical and radiographic pneumonia in children meeting the World Health Organization definition for pneumonia
por: Puumalainen, Taneli, et al.
Publicado: (2008)

Production of inflammatory cytokines in response to diphtheria-pertussis-tetanus (DPT), haemophilus influenzae type b (Hib), and 7-valent pneumococcal (PCV7) vaccines
por: Kashiwagi, Yasuyo, et al.
Publicado: (2014)

A 6-year Prospective, Observational, Multi-Center Post-Marketing Surveillance of the Safety of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis (Tdap) Vaccine in Korea
por: Park, Hee-Jin, et al.
Publicado: (2019)

Vaccination response to tetanus toxoid and 23-valent pneumococcal vaccines following administration of a single dose of abatacept: a randomized, open-label, parallel group study in healthy subjects
por: Tay, Lee, et al.
Publicado: (2007)

Pseudomonas aeruginosa PAO-1 Lipopolysaccharide-Diphtheria Toxoid Conjugate Vaccine: Preparation, Characterization and Immunogenicity
por: Najafzadeh, Faezeh, et al.
Publicado: (2015)

Immunogenicity comparison of conjugate vaccines composed of alginate and lipopolysaccharide of Pseudomonas aeruginosa bound to diphtheria toxoid
por: Najafzadeh, Faezeh, et al.
Publicado: (2014)

Evaluation of Potency on Diphtheria and Tetanus Toxoid for Adult Vaccines by In Vivo Toxin Neutralization Assay Using National Reference Standards
por: Choi, Chan Woong, et al.
Publicado: (2018)

Serum Sickness following Tetanus Toxoid Injection
por: alhawal, Saja, et al.
Publicado: (2021)

Letter to the Editor Regarding: “Cost-Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Versus Lower-Valent Alternatives in Filipino Infants”
por: Gomez, Jorge A., et al.
Publicado: (2022)

Diphtheria, Tetanus, and Pertussis Immunity in Indian Adults and Immunogenicity of Td Vaccine
por: Kulkarni, Prasad S., et al.
Publicado: (2011)

Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine compared to the 23-valent pneumococcal polysaccharide vaccine in elderly Japanese adults
por: Shiramoto, Masanari, et al.
Publicado: (2015)

2709. Immune Response After Diphtheria and Tetanus Toxoid Booster in Patients with Adult-Onset Immunodeficiency with Anti-interferon-γ Autoantibody
por: Tovikkai, Dissaruj, et al.
Publicado: (2019)

Immunogenicity and Safety of a Newly Developed Tetanus-Diphtheria Toxoid (Td) in Healthy Korean Adolescents: a Multi-center, Randomized, Double-blind, Active-Controlled Phase 3 Trial
por: Choi, Ui Yoon, et al.
Publicado: (2021)

Tetanus in Diphtheria Antitoxin
Publicado: (1901)

Engineering of tetanus toxoid-loaded polymeric microneedle patches
por: Arshad, Muhammad Sohail, et al.
Publicado: (2022)

15. Evaluation of Retained Immunity for Tetanus-Diphtheria and Pneumococcal Vaccines in Recipients of Cellular Therapies
por: Angelidakis, Georgios, et al.
Publicado: (2021)

A Response to: Letter to the Editor Regarding “Cost-Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Versus Lower-Valent Alternatives in Filipino Infants”
por: Perdrizet, Johnna, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2v9fagllkrtgkkgfiu5d398s97